| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr1_0870600 | Intergenic-Intergenic | chr1:41537463-41538441 | chr1:41071791-41072769 | 979 nt | 0.4259 |
| hsa_chr1_0870700 | Intergenic-Intergenic | chr1:41537478-41538441 | chr1:41071806-41072769 | 964 nt | 0.4253 |
| hsa_chr1_0870800 | Intergenic-Intergenic | chr1:41537933-41538102 | chr1:41072261-41072430 | 170 nt | 0.3588 |
| hsa_SCMH1_0007200 | Intron-Exon-Intron | chr1:41540891-41571497 | chr1:41075219-41105825 | 250 nt | 0.3720 |
| hsa_SCMH1_0007500 | Exon-Exon | chr1:41540891-41582682 | chr1:41075219-41117010 | 89 nt | 0.4831 |
| hsa_SCMH1_0007600 | Exon-Exon | chr1:41540891-41608784 | chr1:41075219-41143112 | 801 nt | 0.5268 |
| hsa_SCMH1_0007300 | Exon-Exon | chr1:41540891-41618413 | chr1:41075219-41152741 | 1015 nt | 0.5172 |
| hsa_SCMH1_0007400 | Exon-Exon | chr1:41540891-41651922 | chr1:41075219-41186250 | 1304 nt | 0.4709 |
| hsa_chr1_0870900 | Intergenic-Intergenic | chr1:41550855-41551104 | chr1:41085183-41085432 | 250 nt | 0.2920 |
| hsa_SCMH1_0007700 | Intron-Intron | chr1:41560617-41560760 | chr1:41094945-41095088 | 144 nt | 0.4097 |
A study in humans demonstrated that the circSCMH1 is significantly decreased in the plasma of patients with acute ischemic stroke and is significant in predicting stroke outcomes [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in mice demonstrated that exosomes from adipose-derived stem cells delivering the circSCMH1 reduced nerve damage by promoting microglial M2 polarization [Li et al. DOI:10.1016/j.neuint.2023.105643].